(Q53149201)

11 May 2018

meta-analysis

0 references

title

Alzheimer disease and cancer risk: a meta-analysis. (English)

1 reference

11 May 2018

Erratum to: Alzheimer disease and cancer risk: a meta-analysis.

corrigendum / erratum

0 references

author

Guo-jun Chen

5

1 reference

11 May 2018

author name string

Hai-bin Shi

1

1 reference

11 May 2018

Bo Tang

2

1 reference

11 May 2018

Yao-Wen Liu

3

1 reference

11 May 2018

Xue-Feng Wang

4

1 reference

11 May 2018

publication date

12 July 2014

1 reference

11 May 2018

Journal of Cancer Research and Clinical Oncology

published in

1 reference

11 May 2018

volume

141

1 reference

11 May 2018

issue

3

1 reference

11 May 2018

page(s)

485-494

1 reference

11 May 2018

https://scigraph.springernature.com/pub.10.1007/s00432-014-1773-5

exact match

0 references

cites work

Smoking as a risk factor for dementia and cognitive decline: a meta-analysis of prospective studies

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Parkinson's disease and cancer risk: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Operating characteristics of a rank correlation test for publication bias

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

A common biological mechanism in cancer and Alzheimer's disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Diabetes mellitus and risk of pancreatic cancer: A meta-analysis of cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Rapid activation of Stat3 and ERK1/2 by nicotine modulates cell proliferation in human bladder cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Cognitive impairment and diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Inverse association between cancer and Alzheimer's disease: results from the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

21 January 2018

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Regeneration and tissue repair: themes and variations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Alzheimer Disease and Mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Seizures in patients with Alzheimer's disease or vascular dementia: a population-based nested case-control analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Predictors of survival with Alzheimer's disease: a community-based study

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

21 January 2018

12 December 2020

Glycogen synthase kinase-3 (GSK3): inflammation, diseases, and therapeutics

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

The incidence of dementia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Clinical risk factors for Alzheimer's disease: a population-based case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Inhibition of cholinergic signaling causes apoptosis in human bronchioalveolar carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Overexpression and activation of the alpha9-nicotinic receptor during tumorigenesis in human breast epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Moderate reduction of gamma-secretase attenuates amyloid burden and limits mechanism-based liabilities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Endogenous estrogen levels and Alzheimer's disease among postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Epigenetic differences in cortical neurons from a pair of monozygotic twins discordant for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Epigenetics and the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Genetic and environmental factors in cancer and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Inverse occurrence of cancer and Alzheimer disease: a population-based incidence study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Alpha 7 nicotinic acetylcholine receptor expression and activity during neuronal differentiation of PC12 pheochromocytoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Human nicotinic receptors--their role in aging and dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Does Alzheimer's disease protect against cancers? A nationwide population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Prediction of survival in Alzheimer's disease--the LASER-AD longitudinal study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Cancer and neurodegeneration: between the devil and the deep blue sea.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

AD and cancer: epidemiology makes for strange bedfellows.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Alzheimer disease and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Cancer linked to Alzheimer disease but not vascular dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Is cancer triggered by altered signalling of nicotinic acetylcholine receptors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Tumorigenesis and neurodegeneration: two sides of the same coin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Prolyl isomerase, Pin1: new findings of post-translational modifications and physiological substrates in cancer, asthma and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Survival of ethnic Chinese with Alzheimer's disease: a 5-year longitudinal study in Taiwan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

p53 in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Nonmelanoma skin cancer is associated with reduced Alzheimer disease risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Nicotinic acetylcholine receptor-based blockade: applications of molecular targets for cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Life expectancy in Alzheimer's disease (AD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Alzheimer's disease and risk of hip fracture: a meta-analysis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00432-014-1773-5

Alzheimer's disease: recent advances and future perspectives

21 January 2018

1 reference

12 December 2020

Survival of patients with dementia

1 reference

12 December 2020

Nicotinic acetylcholine receptors in Alzheimer's disease

1 reference

12 December 2020

Tumor diagnosis preceding Alzheimer's disease onset: is there a link between cancer and Alzheimer's disease?

1 reference

12 December 2020

Methods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis

1 reference

12 December 2020

Epibatidine and ABT 418 reveal selective losses of alpha 4 beta 2 nicotinic receptors in Alzheimer brains.

1 reference

12 December 2020

10.1007/S00432-014-1773-5

Identifiers

DOI

1 reference

11 May 2018

1 reference

11 May 2018